Clinical Trial Characteristics of Rheumatology Diseases
Clinical studies in the field of rheumatology have a long follow-up cycle, and the patients’ medications are mostly complex and varied. Presently, competition in clinical development is gradually increasing and most of the current clinical trials are with biologicals which have a long half-life and long follow-up period. In these studies, many patients drop out due to intolerable joint pain causing them to change the therapeutic regimen. Additionally, the inclusion and exclusion criteria are strict on requirements regarding the subjects’ prior medication and medical history, therefore the screening failure rate is high.
Advantages of Tigermed
Tigermed has rapidly accumulated significant project management experience for clinical development in rheumatology, especially in rheumatoid arthritis, and also has good cooperation with well-known hospital departments. To cater to the needs of and characteristics of various products, Tigermed formulates project risk management plans and progression plans in a targeted manner, and for our approach, we have received appreciation from investigators for aspects including subject recruitment, follow-up, and monitoring.
Because the enrollment in clinical trials of rheumatoid arthritis is mostly dependent on the recruiting centers to recommend subjects, Tigermed has the support of a professional recruitment team to facilitate successful clinical development.
The rheumatology team is managed by experienced medical directors and project managers that have an average working experience of 5 years.
Our clinical trial experience includes, but is not limited to, the following rheumatology indications:
- Rheumatoid arthritis
- Lupus erythematosus nephropathy